FindTrial
Sign In

Application of Omaha System in Patients with Hypertensive Disorder of Pregnancy and Efficacy Evaluation

Application of Omaha System in Patients with Hypertensive Disorder of Pregnancy and Efficacy Evaluation

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800016670
Enrollment
Unknown
Registered
2018-06-15
Start date
2018-06-15
Completion date
Unknown
Last updated
2018-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertensive Disorder of Pregnancy

Interventions

Intervention group:Omaha System + Routine nursing
Control group:Routine nursing

Sponsors

Shengjing Hospital of China Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 55 Years

Inclusion criteria

Inclusion criteria: (1) The patient's clinical diagnosis and disease condition were in accordance with Xie Yu's Obstetrics and Gynecology (8th Edition) criteria for hypertensive disorder complicating pregnancy; (2) has basic listening, speaking, reading and writing capabilities; (3) Informed consent, voluntary participation;

Exclusion criteria

Exclusion criteria: (1) Primary diabetes, chronic kidney disease, heart disease, intrauterine infection, etc.; (2) Severe heart, liver and kidney dysfunction; (3) Patients with mental illness;

Design outcomes

Primary

MeasureTime frame
Quality of Life;—

Countries

China

Contacts

Public ContactChunling Xia

Shengjing Hospital of China Medical University

xiacl@sj-hospital.org+86 18940251368

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026